Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS)
- Resource Type
- Source
- Lung Cancer. 178:S85-S86
- Subject
Pulmonary and Respiratory Medicine Cancer Research Oncology - Language
- ISSN
- 0169-5002